Scientists hunt clues in blood to unlock new treatment path for bone marrow cancer

This completed study aimed to understand how a specific type of immune cell, called myeloid-derived suppressor cells (MDSCs), contributes to the chronic inflammation and blood vessel growth seen in primary myelofibrosis, a serious bone marrow cancer. Researchers studied blood and bone marrow samples from 70 people (both patients and healthy volunteers) to see if these cells could be a new target for future treatments. The study did not test a new therapy but gathered knowledge to help design better treatments in the future.